Influence of a positive family history of both type 2 diabetes and PCOS on metabolic and endocrine parameters in a large cohort of PCOS women

Eur J Endocrinol. 2014 Apr 10;170(5):727-39. doi: 10.1530/EJE-13-1035. Print 2014 May.

Abstract

Objective: There is evidence suggesting a strong genetic background of polycystic ovary syndrome (PCOS). We aim to study the metabolic and endocrine characteristics of PCOS women with and without a family history (FHx) of type 2 diabetes mellitus (T2DM) and PCOS.

Design: Cross-sectional study.

Methods: We analysed the association of T2DM FHx and PCOS FHx with metabolic and endocrine parameters in 714 PCOS women.

Results: A positive FHx of T2DM and PCOS were prevalent in 36.8 and 21.4% of PCOS women respectively. We found an independent association of T2DM FHx with central fat accumulation, obesity, prediabetes, metabolic syndrome (MS), insulin resistance, low HDL and elevated blood pressure (P<0.05 for all). PCOS FHx was independently associated with prediabetes (P<0.05). We observed an independent association of PCOS FHx with clinical and biochemical hyperandrogenism (P<0.05 for all), whereas there was no independent association of T2DM FHx with hyperandrogenism. PCOS women with a positive FHx of both T2DM and PCOS had an adverse metabolic and endocrine profile including a linear increase in risk of obesity, central fat accumulation, MS, prediabetes and low HDL (P<0.05 for all).

Conclusions: Our findings suggest that the assessment of FHx might allow risk stratification of PCOS women, which is important considering the high prevalence of PCOS.

MeSH terms

  • Abdominal Fat / pathology
  • Adiposity
  • Adult
  • Austria / epidemiology
  • Body Mass Index
  • Cohort Studies
  • Cross-Sectional Studies
  • Diabetes Mellitus, Type 2 / epidemiology*
  • Diabetes Mellitus, Type 2 / physiopathology
  • Dyslipidemias / epidemiology
  • Dyslipidemias / physiopathology
  • Family Health*
  • Female
  • Humans
  • Hyperandrogenism / epidemiology
  • Hyperandrogenism / physiopathology
  • Hypertension / epidemiology
  • Hypertension / physiopathology
  • Insulin Resistance
  • Metabolic Syndrome / epidemiology
  • Metabolic Syndrome / physiopathology
  • Obesity / epidemiology
  • Obesity / physiopathology
  • Polycystic Ovary Syndrome / blood
  • Polycystic Ovary Syndrome / epidemiology*
  • Polycystic Ovary Syndrome / etiology
  • Polycystic Ovary Syndrome / pathology
  • Prediabetic State / epidemiology
  • Prediabetic State / physiopathology
  • Risk Factors